Latest Regulatory News

AUB Group Limited has disclosed a conditional, non-binding proposal from an EQT affiliate to acquire the company at $45 per share, following unusual trading activity and media reports.

Winsome Resources has completed a focused drilling campaign at its Adina Lithium Project and revealed new high-grade cesium-lithium mineralised zones at Sirmac-Clapier, while strengthening its stake in Power Metals Corp.

Wia Gold Limited has delivered a robust Scoping Study for its Kokoseb Gold Project in Namibia, confirming strong production potential and cost efficiency. The company also secured A$30 million to accelerate exploration and development activities.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

NH3 Clean Energy has secured key government approval that streamlines regulatory processes for its WAH2 low-emissions ammonia project, keeping it on track for first production by 2026. This milestone underscores growing state support for decarbonisation initiatives in Western Australia’s strategic industrial zones.

Resouro Strategic Metals has engaged Independent Trading Group to provide market-making services on the TSX Venture Exchange, aiming to enhance liquidity and trading efficiency for its shares. This move comes as the company continues to advance its significant Brazilian mineral projects.

Heavy Rare Earths Limited has completed the acquisition of an 80% interest in the Prospect Hill Tin Project, South Australia’s most advanced tin asset, setting the stage for a swift maiden resource estimate.

Australian authorities have executed a search warrant at WiseTech Global's Sydney office amid an investigation into alleged insider trading involving the company's founder and employees. No charges have been filed, and the company pledges full cooperation.

Arovella Therapeutics has secured encouraging feedback from the US FDA on reagent testing for its CAR-iNKT cell therapy, setting the stage for an IND filing this quarter and clinical trials in early 2026.

BetMakers Technology Group kicks off FY26 with a strong financial turnaround and strategic advances, including a promising acquisition and digital wagering expansion in Nevada.

BetMakers Technology Group has reported a remarkable 361% growth in adjusted EBITDA for Q1 FY26, driven by strong revenue gains and operational efficiencies, while advancing its strategic expansion into the Las Vegas racing market.

Memphasys has signed a pivotal supply agreement with Andro Diagnostics to distribute its Felix™ sperm separation system across over 200 IVF clinics in India, marking a major step in its new global go-direct commercial strategy.